The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
- PMID: 17631127
- DOI: 10.1053/j.gastro.2007.04.005
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects
Abstract
Background & aims: Irritable bowel syndrome (IBS) is a significant gastrointestinal disorder with unknown etiology. The symptoms can greatly weaken patients' quality of life and account for notable economical costs for society. Contribution of the gastrointestinal microbiota in IBS has been suggested. Our objective was to characterize putative differences in gastrointestinal microbiota between patients with IBS and control subjects. These differences could potentially have a causal relationship with the syndrome.
Methods: Microbial genomes from fecal samples of 24 patients with IBS and 23 controls were collected, pooled in a groupwise manner, and fractionated according to their guanine cytosine content. Selected fractions were analyzed by extensive high-throughput 16S ribosomal RNA gene cloning and sequencing of 3753 clones. Some of the revealed phylogenetic differences were further confirmed by quantitative polymerase chain reaction assays on individual samples.
Results: The coverage of the clone libraries of IBS subtypes and control subjects differed significantly (P < .0253). The samples were also distinguishable by the Bayesian analysis of bacterial population structure. Moreover, significant (P < .05) differences between the clone libraries were found in several bacterial genera, which could be verified by quantitative polymerase chain reaction assays of phylotypes belonging to the genera Coprococcus, Collinsella, and Coprobacillus.
Conclusions: The study showed that fecal microbiota is significantly altered in IBS. Further studies on molecular mechanisms underlying these alterations are needed to elucidate the exact role of intestinal bacteria in IBS.
Comment in
-
Irritable bowel syndrome: shifting the focus toward the gut microbiota.Gastroenterology. 2007 Jul;133(1):340-2. doi: 10.1053/j.gastro.2007.05.030. Gastroenterology. 2007. PMID: 17631152 No abstract available.
-
Studying the human microbiome: beyond the petri dish.Curr Gastroenterol Rep. 2008 Aug;10(4):393-4. Curr Gastroenterol Rep. 2008. PMID: 18627651 No abstract available.
Similar articles
-
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.Am J Gastroenterol. 2005 Feb;100(2):373-82. doi: 10.1111/j.1572-0241.2005.40312.x. Am J Gastroenterol. 2005. PMID: 15667495
-
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.Gastroenterology. 2011 Nov;141(5):1792-801. doi: 10.1053/j.gastro.2011.07.043. Epub 2011 Aug 5. Gastroenterology. 2011. PMID: 21820992
-
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.World J Gastroenterol. 2009 Dec 21;15(47):5936-45. doi: 10.3748/wjg.15.5936. World J Gastroenterol. 2009. PMID: 20014457 Free PMC article.
-
Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.Am J Gastroenterol. 2008 Jun;103(6):1557-67. doi: 10.1111/j.1572-0241.2008.01869.x. Epub 2008 May 29. Am J Gastroenterol. 2008. PMID: 18513268 Review.
-
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.Dig Liver Dis. 2017 Apr;49(4):331-337. doi: 10.1016/j.dld.2017.01.142. Epub 2017 Jan 21. Dig Liver Dis. 2017. PMID: 28179092 Review.
Cited by
-
Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.Dig Dis Sci. 2023 May;68(5):1677-1690. doi: 10.1007/s10620-022-07700-8. Epub 2022 Nov 14. Dig Dis Sci. 2023. PMID: 36376576 Review.
-
Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data.PeerJ. 2013 Feb 26;1:e32. doi: 10.7717/peerj.32. Print 2013. PeerJ. 2013. PMID: 23638368 Free PMC article.
-
The Microbiome: a Revolution in Treatment for Rheumatic Diseases?Curr Rheumatol Rep. 2016 Oct;18(10):62. doi: 10.1007/s11926-016-0614-8. Curr Rheumatol Rep. 2016. PMID: 27641915 Review.
-
The immune system in irritable bowel syndrome.J Neurogastroenterol Motil. 2011 Oct;17(4):349-59. doi: 10.5056/jnm.2011.17.4.349. Epub 2011 Oct 31. J Neurogastroenterol Motil. 2011. PMID: 22148103 Free PMC article.
-
Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.Gut. 2023 Mar;72(3):451-459. doi: 10.1136/gutjnl-2021-326828. Epub 2022 Sep 28. Gut. 2023. PMID: 36171082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases